Warning letter
KV Pharmaceutical Company: warning letter of May 9, 2000
FDA warning letter UCM068414 · Kansas City District Office
Key facts
| Reference number | UCM068414 |
|---|---|
| Company | KV Pharmaceutical Company |
| Subject | Drug Manufacturing Operations/CGMP deviations |
| Issue date | May 9, 2000 |
| Posted date | May 9, 2000 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| CFR sections cited | 211.80(a), 210, 211, 211.100(a) |
| Country | 3 |
| Inspection city | Maryland Heights |
| Inspection ZIP | 63043-2413 |
| Inspection start date | Feb 7, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: